Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD

Aug 22, 2025

Using biomarker testing and APOE genotyping to determine patient eligibility for amyloid-targeting therapies.

Credit available for this activity expires: 8/19/2026

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002844?ecd=bdc_podcast_libsyn_mscpedu